S

Researcher Profile

Stephen Begbie

3

Publications

1,040

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article Nature Medicine Oct 20, 2025

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

Jeanne Tie · Yuxuan Wang · Jonathan M. Loree · Joshua D. Cohen +80 more

10.1038/s41591-025-04030-w 21 citations

Journal Article The Lancet Jun 01, 2023

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley · Makoto Ueno · Changhoon Yoo · Richard S Finn +197 more

10.1016/s0140-6736(23)00727-4 856 citations

Journal Article The Lancet Oncology Apr 01, 2023

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

Christopher J Sweeney · Andrew J Martin · Martin R Stockler · Stephen Begbie +96 more

10.1016/s1470-2045(23)00063-3 163 citations

Publication Timeline

2025

1

2023

2

Frequent Co-Authors

Craig Underhill

Narayan Karanth

Aflah Roohullah

Margaret McJannett

Naureen Starling

Tomonori Mizutani